Toxic genomic
Toxic genomic In this report, toxic genomic is well-defined as the application of genomic technologies (for example, genetics, genome sequence analysis, gene expression profiling, proteomics, metabolomics, and related approaches) to study the adverse effects of environmental and pharmaceutical chemicals on human health and the environment. Researchers, regulators, and the public all desire efficient and correct methods to assess the toxicologic effects of chemical, physical, and biologic agents on living systems. Yet, no single approach happens to analyse toxicologic responses, a tough task given the complexity of human and animal physiology and individual variations. The genomic information and novel technologies that have appeared in the post-genomic time promise to inform the thoughtful of many risks as well as enlighten current approaches and lead to novel predictive approaches for studying disease risk.
Related Conference of Toxic genomic
7th International Conference on Clinical Pharmacology and Toxicology
Toxic genomic Conference Speakers
Recommended Sessions
- Analytical Toxicology
- Aquatic Toxicology
- Behavior Toxicology
- Chemical Toxicology
- Clinical Pharmacological
- Ecological Risk Assessment
- Experimental and Toxicologic Pathology
- Human Health Toxicology
- Immuno Toxicology
- In Vitro Toxicology
- Medical Development and Safety Testing
- Microbial Toxicology
- Nano toxicology
- Pharmacology
- Toxic genomic
- Toxicology
Related Journals
Are you interested in
- Adverse Drug Reactions and Pharmacovigilance - clinical pharmacology 2025 (Switzerland)
- Cardiovascular Pharmacology - clinical pharmacology 2025 (Switzerland)
- Clinical Toxicology of Drugs of Abuse - clinical pharmacology 2025 (Switzerland)
- Clinical Trials and Regulatory Affairs - clinical pharmacology 2025 (Switzerland)
- Drug Interactions and Polypharmacy - clinical pharmacology 2025 (Switzerland)
- Emerging Trends in Clinical Pharmacology - clinical pharmacology 2025 (Switzerland)
- Environmental and Occupational Toxicology - clinical pharmacology 2025 (Switzerland)
- Future Directions in Clinical Pharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Innovations in Drug Development and Therapeutics - clinical pharmacology 2025 (Switzerland)
- Natural Products and Toxicology - clinical pharmacology 2025 (Switzerland)
- Neuropharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Pediatric and Geriatric Pharmacology - clinical pharmacology 2025 (Switzerland)
- Pharmacogenomics and Personalized Medicine - clinical pharmacology 2025 (Switzerland)
- Pharmacokinetics and Pharmacodynamics - clinical pharmacology 2025 (Switzerland)
- Toxicology and Risk Assessment - clinical pharmacology 2025 (Switzerland)